| Followers | 47 |
| Posts | 12038 |
| Boards Moderated | 0 |
| Alias Born | 09/12/2017 |
Saturday, January 13, 2024 2:42:31 PM
The Company’s drug candidate, VyrologixTM, also known as leronlimab (PRO 140),
https://www.sec.gov/Archives/edgar/data/1175680/000119312521091607/filename1.htm
From: TMOfficialNotices@USPTO.GOV
Sent: Tuesday, September 6, 2022 06:15 PM
To: XXXX
Subject: Official USPTO Notification: U.S. Trademark SN 88877284 -- Docket/Reference No. 230042.213
OFFICIAL USPTO NOTICE OF ABANDONMENT
TRADEMARK APPLICATION ABANDONED - FAILURE TO FILE TIMELY SOU OR EXTENSION REQUEST
U.S. Application Serial No. 88877284
Mark: VYROLOGIX (Stylized/Design)
Owner: CytoDyn Inc.
Docket/Reference No. 230042.213
Issue Date: September 06, 2022
The application above is abandoned because we did not receive within six months of the Notice of Allowance (NOA) issue date:
(1) A Statement of Use (SOU); or
(2) A Request for Extension of Time to File a Statement of Use (Extension Request).
Hmmm, trademark abandoned? How many times since then has mgt went back to the well begging for more share authorizations and what about those hefty salaries that go along with it?
Recent CYDY News
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM
